enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - mellnövekedés - daganatellenes szerek - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
quetiapine-ratiopharm 300 mg filmtabletta
ratiopharm gmbh - quetiapine -
panadol baby 24 mg/ml belsőleges szuszpenzió
glaxosmithkline-consumer kft. - a paracetamol -
obradon 20 mg filmtabletta
pfizer kft. - atorvastatin -
dianeal pd4 glucose 3,86% peritoneális dializáló oldat
baxter (hungary) kft. - electrolits; glükóz-monohidrát - hypertonic solutions
tineal 250 mg tabletta
goodwill pharma kft. - terbinafin -
simvastatin arrow 80 mg filmtabletta
arrow generics ltd. - szimvasztatin -
sertraline aurobindo 50 mg filmtabletta
aurobindo pharma ltd. - szertralin -
risperidone-arrow 2 mg filmtabletta
arrow generics ltd. - riszperidon -